Start your Trading & Investing Journey with us
Join our channel for Daily Free Trades with Live analysis on Youtube, Trade Setup with Important Levels, and Important Stock Market Updates
Sudeep Pharma IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details
IPO Details
IPO GMP
IPO Subscription
Reviews
About Company
IPO Timeline
KPI
Financial Information
Peer Comparison
Allotment
Sudeep Pharma Limited IPO : Key Performance Indicators, PE Ratio, EPS, ROE, ROCE & RoNW
The Company Key Performance Indicates the pre-issue EPS of ₹12.78and post-issue EPS of ₹12.28 for FY25. The pre-issue P/E ratio is46.40x, while the post-issue P/E ratio is48.29x against the Industry P/E ratio is NA The company's ROE for FY25 is 28.13% and RoNW is 27.88%. The Annualised EPS is ₹11.07x and P/E is
53.55x. These metrics suggest that the IPO is Fully priced.
Key Performance Indicator
| KPI | Values |
|---|---|
| EPS Pre IPO (Rs.) | 12.78 |
| EPS Post IPO (Rs.) | 12.28 |
| Adjusted 12M EPS Post IPO (Rs.) | 11.07 |
| P/E Pre IPO | 46.40 |
| P/E Post IPO | 48.29 |
| Adjusted 12M P/E Post IPO | 53.55 |
| ROE | 28.13% |
| ROCE | 29.82% |
| P/BV | 12.93 |
| Debt/Equity | 0.2 |
| RoNW | 27.88% |
| EBITDA Margin | 39.70% |
| PAT Margin | 27.12% |
